Ustar Nets Over $47M In Series E+ Round
12/03/21, 1:39 AM
Location
hangzhou
Money raised
$47 million
Round Type
series e
Hangzhou-headquartered biotechnology company Ustar Biotechnologies (Hangzhou) Ltd has raised over 300 million yuan ($47 million) in its Series E+ round, per a company statement on Tuesday.